EMF biological effects
Share

Treatment with electromagnetic field alters the clinical course of chronic progressive multiple sclerosis--a case report.

R Sandyk

PAPERpubmedThe International journal of neuroscience1996Case reportEffect: benefitEvidence: Very low

Abstract

It is estimated that 10-20% of patients with multiple sclerosis (MS) have a chronic progressive (CP) course characterized by an insidious of neurological deficits followed by steady progression of disability in the absence of symptomatic remission. No therapeutic modality has shown specific efficacy in the treatment of patients with CP MS and there are no data to indicate that any pharmacologic or other modality alters the clinical course of CP MS. Treatment with picotesla electromagnetic fields (EMFs) is a highly effective modality for the symptomatic management of MS including the chronic progressive form. In addition, this treatment also appears to alter the natural course of the disease in CP patients. A 36 year-old man experienced, at the age of 31, insidious weakness in the legs and several months later developed difficulties with balance with ataxia of gait. His gait abnormality progressed slowly over the following years and at the age of 35 he was severely disabled with spastic paraparesis and ataxia using a rolling walker for ambulation and a scooter for longer distances. In particular, his disability had progressed rapidly over the six months preceding the initiation of treatment with EMFs. He as classified have CP MS and his prognosis was considered extremely unfavorable due to the degree of cerebellar and pyramidal tract involvement and the rapid course of deterioration. In July 1995 the patient began experimental treatment with EMFs. While receiving three treatment sessions a week over 12 months he experienced improvement in cerebellar functions such as gait, balance and tremor as well as bowel and bladder functions, mood, sleep and cognitive function and resolution of diplopia, blurring of vision, dysarthria, paresthesias in the hands, and fatigue. Most remarkably, there was no further progression of the disease during the course of magnetic therapy. This case illustrated that treatment with EMFs, in addition to producing symptomatic improvement, also reverses the clinical course of CP MS.

AI evidence extraction

At a glance
Study type
Case report
Effect direction
benefit
Population
Patient with chronic progressive multiple sclerosis (36-year-old man)
Sample size
1
Exposure
therapeutic electromagnetic field treatment (picotesla EMFs) · three treatment sessions per week over 12 months
Evidence strength
Very low
Confidence: 78% · Peer-reviewed: yes

Main findings

In a single patient with chronic progressive multiple sclerosis receiving experimental picotesla electromagnetic field treatment three times weekly for 12 months, the report describes symptomatic improvements (including gait, balance, tremor, bowel/bladder function, mood, sleep, cognition, and resolution of several symptoms) and states there was no further disease progression during treatment.

Outcomes measured

  • Progression of chronic progressive multiple sclerosis
  • Gait/balance/ataxia
  • Tremor
  • Bowel and bladder function
  • Mood
  • Sleep
  • Cognitive function
  • Diplopia/visual symptoms
  • Dysarthria
  • Paresthesias in hands
  • Fatigue

Limitations

  • Single-patient case report
  • No control/comparator described
  • Experimental treatment
  • details of EMF parameters (e.g.
  • frequency) not provided in abstract
  • Outcomes appear largely clinical/symptom-based without standardized measures reported in abstract
View raw extracted JSON
{
  "study_type": "case_report",
  "exposure": {
    "band": null,
    "source": "therapeutic electromagnetic field treatment (picotesla EMFs)",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": "three treatment sessions per week over 12 months"
  },
  "population": "Patient with chronic progressive multiple sclerosis (36-year-old man)",
  "sample_size": 1,
  "outcomes": [
    "Progression of chronic progressive multiple sclerosis",
    "Gait/balance/ataxia",
    "Tremor",
    "Bowel and bladder function",
    "Mood",
    "Sleep",
    "Cognitive function",
    "Diplopia/visual symptoms",
    "Dysarthria",
    "Paresthesias in hands",
    "Fatigue"
  ],
  "main_findings": "In a single patient with chronic progressive multiple sclerosis receiving experimental picotesla electromagnetic field treatment three times weekly for 12 months, the report describes symptomatic improvements (including gait, balance, tremor, bowel/bladder function, mood, sleep, cognition, and resolution of several symptoms) and states there was no further disease progression during treatment.",
  "effect_direction": "benefit",
  "limitations": [
    "Single-patient case report",
    "No control/comparator described",
    "Experimental treatment; details of EMF parameters (e.g., frequency) not provided in abstract",
    "Outcomes appear largely clinical/symptom-based without standardized measures reported in abstract"
  ],
  "evidence_strength": "very_low",
  "confidence": 0.78,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "multiple sclerosis",
    "chronic progressive",
    "picotesla",
    "electromagnetic fields",
    "magnetic therapy",
    "case report"
  ],
  "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 4262

Treatment with electromagnetic field alters the clinical course of chronic progressive multiple sclerosis--a case report. · Non-native EMF